THE VACCINE ADDITIVE THIMEROSAL: CAUSATION AND COMPENSATION FOR CHILDREN WITH AUTISM

DSpace/Manakin Repository

THE VACCINE ADDITIVE THIMEROSAL: CAUSATION AND COMPENSATION FOR CHILDREN WITH AUTISM

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Ray, Amy W. en_US
dc.date.accessioned 2012-07-06T22:05:18Z
dc.date.issued 2003 en_US
dc.identifier.citation THE VACCINE ADDITIVE THIMEROSAL: CAUSATION AND COMPENSATION FOR CHILDREN WITH AUTISM (2003 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965619
dc.description.abstract . This Paper explores the complex thimerosal debate. Part II briefly sets out the history of vaccine manufacturers in the last half of the twentieth century culminating with the passage of the Vaccine Act; it also posits frequent criticisms of the VICP. Part III discusses the theorized thimerosal-autism link and recounts failures and minor successes of parents of autistic children in various tribunals in the past year. The innovative evidentiary solution offered by the Court of Federal Claims, the Omnibus Autism Proceeding, is the focus of Part IV. Lastly, Part V concludes with implications of the thimerosal dispute, including an analysis of relevant provisions in the proposed National Vaccine Injury Compensation Program Improvement Act of 2003. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject vaccine injuries en
dc.subject vaccination risks en
dc.subject Thimerosal en
dc.subject autism en
dc.title THE VACCINE ADDITIVE THIMEROSAL: CAUSATION AND COMPENSATION FOR CHILDREN WITH AUTISM en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T22:05:18Z

Files in this item

Files Size Format View
Ray.pdf 35.07Kb PDF View/Open
Ray.rtf 198.1Kb RTF file View/Open
Ray.html 157.5Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters